GlobeNewswire·Apr 30, 2026, 4:05 PM ET

Exponent Reports First Quarter 2026 Financial Results

EXPO

Exponent, Inc. reported first-quarter fiscal 2026 financial results ending April 3, 2026, with total revenues increasing 14% to $166.3 million & revenues before reimbursements rising 10% to $151.8 million.
Net income for the quarter increased to $29.6 million ($0.59 per diluted share) from $26.7 million ($0.52 per share) in the same period last year, with a consolidated tax rate of 30.2%.
EBITDA grew to $43.1 million, representing 28.4% of net revenues, compared to $37.5 million or 27.3% in the prior year quarter.
Growth was driven by proactive engagements in consumer electronics user research & utility risk management, alongside reactive demand for dispute resolution & failure analysis in construction, energy, & medical devices.
The engineering & scientific segment accounted for 85% of revenues before reimbursements with a 12% year-over-year increase, while the environmental & health segment represented 15% with a 2% increase.
During the quarter, Exponent paid $16.6 million in dividends, repurchased $78.8 million of common stock, & ended with $118.6 million in cash & cash equivalents.
The Board approved a $50 million increase to the stock repurchase program, bringing total available funds for repurchases to $67.7 million, & declared a quarterly dividend of $0.31 payable on June 18, 2026.
Full-year 2026 guidance remains unchanged, anticipating revenues before reimbursements to grow in the high-single digits & EBITDA to be 27.6% to 28.1% of such revenues.
Management cited 5% headcount growth, 76% utilization, & strong rate realization as key drivers for the strong first quarter.
Leadership updates include John Pye & Eric Anderson joining key roles to support innovation & operational expertise, while Richard Schlenker continues as CFO & was nominated for the Board.